Pay in 4 interest-free payments of $7.21 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
As I gain more experience with patients, my knowledge base grows and evolves
Kaisers 2026 formulary includes six GLP-1 medications: Wegovy (semaglutide for obesity and CVD), Zepbound (tirzepatide for obesity and OSA), Ozempic (semaglutide for type 2 diabetes), Mounjaro (tirzepatide for type 2 diabetes), Saxenda (liraglutide for obesity), and Rybelsus (oral semaglutide for type 2 diabetes)
The only current exceptions are Rybelsus , an oral pill for type 2 diabetes, and, recently in 2026, Wegovy the first oral GLP-1 drug available for weight loss
The dosing chart below outlines the available microdose levels for treatment and the typical next step if your doctor decides to adjust your dose every two weeks
US$ 23.70
US$ 27.76
US$ 23.14
US$ 23.59
US$ 28.10
US$ 26.45
US$ 20.47
US$ 27.74
US$ 29.66
US$ 24.12
